Cargando…

AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease

Alzheimer's disease (AD) is the most common form of dementia in elder people, characterised by a progressive decline in memory as a result of an impairment of cholinergic neurotransmission. To date acetylcholinesterase inhibitors (AChEIs) have become the most prescribed drugs for the symptomati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yu, Wang, Hao, Chen, Hong-zhuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876592/ https://www.ncbi.nlm.nih.gov/pubmed/26786145 http://dx.doi.org/10.2174/1570159X14666160119094820

Ejemplares similares

MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
por: Shamsi, Anas, et al.
Publicado: (2020)

Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy
por: Murray, Ana Paula, et al.
Publicado: (2013)

Screening and analysis of acetyl-cholinesterase (AChE) inhibitors in the context of Alzheimer's disease
por: Khan, Mohd. Babu, et al.
Publicado: (2018)

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
por: Unzeta, Mercedes, et al.
Publicado: (2016)

Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer’s Disease
por: Rossi, Michele, et al.
Publicado: (2021)

Advances in Multi-Functional Ligands and the Need for Metal-Related Pharmacology for the Management of Alzheimer Disease
por: Sharma, Abha, et al.
Publicado: (2018)

Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study
por: Bak, Andrzej, et al.
Publicado: (2019)

Molecular Investigations of Protriptyline as a Multi-Target Directed Ligand in Alzheimer's Disease
por: Bansode, Sneha B., et al.
Publicado: (2014)

Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease
por: Jones, Michael R., et al.
Publicado: (2017)

In Vitro and In Vivo Anti-AChE and Antioxidative Effects of Schisandra chinensis Extract: A Potential Candidate for Alzheimer's Disease
por: Song, Xinmeng, et al.
Publicado: (2020)

Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer’s disease
por: Sang, Zhipei, et al.
Publicado: (2021)

Structural Isomerism and Enhanced Lipophilicity of Pyrithione Ligands of Organoruthenium(II) Complexes Increase Inhibition on AChE and BuChE
por: Kladnik, Jerneja, et al.
Publicado: (2020)

Design and Synthesis of Ranitidine Analogs as Multi-Target Directed Ligands for the Treatment of Alzheimer’s Disease
por: Gao, Jie, et al.
Publicado: (2021)

Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo
por: Stern, Noa, et al.
Publicado: (2022)

Discovery of Novel Tryptanthrin Derivatives with Benzenesulfonamide Substituents as Multi-Target-Directed Ligands for the Treatment of Alzheimer’s Disease
por: Wang, Guoxing, et al.
Publicado: (2023)

Derivatives of the β-Crinane Amaryllidaceae Alkaloid Haemanthamine as Multi-Target Directed Ligands for Alzheimer’s Disease
por: Kohelová, Eliška, et al.
Publicado: (2019)

Sulfonium Ligands of the α7 nAChR
por: Horenstein, Nicole A., et al.
Publicado: (2021)

Design, synthesis and evaluation of quinolinone derivatives containing dithiocarbamate moiety as multifunctional AChE inhibitors for the treatment of Alzheimer’s disease
por: Fu, Jie, et al.
Publicado: (2019)

Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors
por: ŞAHİN, Kader, et al.
Publicado: (2020)

Readthrough acetylcholinesterase (AChE-R) and regulated necrosis: pharmacological targets for the regulation of ovarian functions?
por: Blohberger, J, et al.
Publicado: (2015)

Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease
por: Agis-Torres, Angel, et al.
Publicado: (2014)

Ajmalicine and Reserpine: Indole Alkaloids as Multi-Target Directed Ligands Towards Factors Implicated in Alzheimer’s Disease
por: Kashyap, Priya, et al.
Publicado: (2020)

Novel Coumarin–Pyridine Hybrids as Potent Multi-Target Directed Ligands Aiming at Symptoms of Alzheimer’s Disease
por: Babaei, Elaheh, et al.
Publicado: (2022)

Common SAR Derived from Linear and Non-linear QSAR Studies on AChE Inhibitors used in the Treatment of Alzheimer’s Disease
por: Pulikkal, Babitha Pallikkara, et al.
Publicado: (2017)

Novel Dual AChE and ROCK2 Inhibitor Induces Neurogenesis via PTEN/AKT Pathway in Alzheimer’s Disease Model
por: Moreira, Natália Chermont dos Santos, et al.
Publicado: (2022)

Silanetriols as in vitro inhibitors for AChE
por: Blunder, Martina, et al.
Publicado: (2011)

Design, Synthesis, and Biological Evaluation of Notopterol Derivatives as Triple Inhibitors of AChE/BACE1/GSK3β for the Treatment of Alzheimer’s Disease
por: Wang, Nan, et al.
Publicado: (2022)

Interactions of AChE with Aβ Aggregates in Alzheimer’s Brain: Therapeutic Relevance of IDN 5706
por: Carvajal, Francisco J., et al.
Publicado: (2011)

First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease
por: Guieu, Benjamin, et al.
Publicado: (2020)

Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs
por: Cetin, Hakan, et al.
Publicado: (2020)

Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design
por: Kumar, Akhil, et al.
Publicado: (2018)

From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer’s Disease
por: Alarcón-Espósito, Jazmín, et al.
Publicado: (2021)

Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
por: Ettcheto, Miren, et al.
Publicado: (2019)

Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model
por: Wang, Ju, et al.
Publicado: (2021)

Development of Activity Rules and Chemical Fragment Design for In Silico Discovery of AChE and BACE1 Dual Inhibitors against Alzheimer’s Disease
por: Bao, Le-Quang, et al.
Publicado: (2023)

Lipooxygenase inhibition in osteoarthritis: a potential symptomatic and disease modifying effect?
por: Dougados, Maxime
Publicado: (2008)

Modified Tacrine Derivatives as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Synthesis, Biological Evaluation, and Molecular Modeling Study
por: Fares, Salma, et al.
Publicado: (2023)

Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer’s disease
por: Hafez, Donia E., et al.
Publicado: (2023)

Correction to Design, Synthesis, and Biological Evaluation of Notopterol Derivatives as Triple Inhibitors of AChE/BACE1/GSK3β for the Treatment of Alzheimer’s Disease
por: Wang, Nan, et al.
Publicado: (2022)

Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach
por: Morató, Xavier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rs8k12ssump628qm0pgfsk4lqs